Q32 Bio Inc to Report 36-Week Topline Results Transcript
Good morning, everyone. Welcome to the Q32 Bio conference call. (Operator Instructions)
Be advised that this call is being recorded at the company's request, and a replay will be available in the Investors section of the company's website following the call.
I will now turn the call over to Lee Kalowski, President and Chief Financial Officer of Q32 Bio. Lee, you may begin.
Thank you, operator, and thank you all for joining us on today's call. Before we begin, I would like to remind you of the disclaimer outlined on slide 2. During today's presentation, including during the question-and-answer portion of the call, we will be making certain forward-looking statements.
A summary of these forward-looking statements and the related risks and uncertainties are outlined on the slide. These can be referenced in our company filings made with the SEC, including our most recent 10-K filing for the fiscal year ended December 31, 2025, and our subsequent 10-Q filing for the first
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
